- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03257007
Mindfulness to Enhance Quality of Life and Support Advance Care Planning (MEANING)
Mindfulness to Enhance Quality of Life and Support Advance Care Planning (MEANING): A Randomized Controlled Pilot Trial for Adults With Metastatic Cancer and Their Family Caregivers
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Mindfulness meditation practices have reduced emotional distress, avoidant coping, and improved spiritual well-being in adult cancer patients. These beneficial effects may occur through present-moment acceptance of unpleasant thoughts, feelings, and circumstances and adaptive coping through self-awareness, self-regulation, and self-transcendence. Most mindfulness trials in cancer have focused on early-stage survivors; however, preliminary evidence suggests that mindfulness may help reduce distress in patients with advanced cancer and their family caregivers (FCGs).
Sixty patients with an advanced-stage solid malignancy and their FCGs (60 dyads) will be randomized in equal numbers to receive either the 6-week mindfulness intervention or usual care. Both groups will receive standard cancer care throughout the study period. Dyads randomized to the mindfulness arm will learn mindfulness meditation practices (e.g., body scan, sitting meditation) and mindful communication practices to enhance quality of life, support advance care planning engagement, and improve a variety of secondary outcomes.
The study will use a mixed methods 2-arm randomized design to examine the effects of the mindfulness intervention compared to usual care and seek to explain trial results using insights gleaned from post-intervention qualitative interviews.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Indiana
-
Indianapolis, Indiana, États-Unis, 46202
- Indiana University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria-Patients
- Patient is at least 18 years of age.
- Patient is at least 3 weeks post-diagnosis of an incurable (locally advanced or metastatic) solid malignancy.
- Patient's attending medical oncologist would not be surprised if the patient died in the next 12 months.
- Patient has not completed a POST form.
- Patient scores ≥ 7 on the Mini-Mental Adjustment to Cancer cognitive avoidance subscale.
- Patient is willing and able to consent and travel to the class location for 6 weekly 2-hour sessions.
- Patient has a family member or close friend eligible and interested in participating in the study.
- Patient has adequate English fluency for completion of data collection
Inclusion Criteria-Family Care Givers (FCG)
- FCG is at least 18 years of age.
- FCG has been invited to participate in the trial with a patient who meets eligibility criteria above.
- FCG is willing and able to consent and travel to the class location for 6 weekly 2-hour sessions.
- FCG has adequate English fluency for completion of data collection
Exclusion Criteria-Patients
- Patient reports a score of > 2 on the Activities and Function item from the Patient Generated Subjective Global Assessment91 (PG-SGA; the patient-reported version of the Eastern Cooperative Oncology Group score).
- Patient makes 3 or more errors on a validated 6-item cognitive screener or exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.
- Currently receiving hospice care (patients who enroll in hospice during the trial will have the option of continuing trial participation).
Exclusion Criteria-FCGs
• FCG exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Aucune intervention: Usual Care
Participants assigned to Usual Care will continue to receive standard care from their oncology team, including access to supportive care from oncology social workers.
At the end of the study, usual care dyads will receive a packet of informational materials on mindfulness meditation, receive a CD with 5 mindfulness meditation practices, and meet with the study interventionist for guidance on how to use the materials and mindfulness recordings to their advantage in coping with cancer-related challenges.
|
|
Comparateur actif: Mindfulness
The Mindfulness intervention will consist of six 2-hour sessions that will include guided mindfulness practices, didactics, and group discussion.
The course curriculum is modeled on the Mindfulness-Based Stress Reduction program which involves intensive experiential training of participants in secular mindfulness meditation practices (i.e., body scan, sitting meditation, gentle hatha yoga with chair adaptations, compassion meditation), with an emphasis on embodying interpersonal mindfulness in dialogue.
|
The Mindfulness intervention sessions are designed to cultivate present-moment awareness in everyday life to facilitate adaptive and non-reactive relating to thoughts, feelings, and bodily sensations.
Participants will be provided with 10-20 minute audio recordings of each of 5 mindfulness practices covered in class, recorded in the facilitator's voice.
Participants will be encouraged to practice mindfulness at home 10-20 minutes per day, 6 days per week.
Participants will be provided with weekly diaries on which to record type and amount of home practice of mindfulness skills.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Change from baseline in quality of life (QoL) for Patients
Délai: Baseline, 6 weeks, and 10 weeks
|
QoL for patients will be assessed with the McGill Quality of Life Inventory.
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in quality of life (QoL) for Family Caregivers
Délai: Baseline, 6 weeks, and 10 weeks
|
QoL for family caregivers will be assessed with the Caregiver Quality of Life - Cancer scale (CQoLC).
|
Baseline, 6 weeks, and 10 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Change from baseline in advance care planning (ACP) stage of change
Délai: Baseline, 6 weeks, and 10 weeks
|
ACP stage of change will be assessed by a measure modified from Fried et.
al assessing stage of change for 3 advance care planning behaviors (completing a living will, medical power of attorney form, or POLST form; patient only measure).
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in advance care planning (ACP) engagement
Délai: Baseline, 6 weeks, and 10 weeks
|
ACP engagement (self-efficacy, readiness) will be measured using 2 subscales of the Advance Care Planning Engagement Survey (patient only measure).
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in caregiver burden
Délai: Baseline, 6 weeks, and 10 weeks
|
Caregiver burden will be measured using the Zarit Burden Interview (family caregiver measure only)
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in avoidant coping
Délai: Baseline, 6 weeks, and 10 weeks
|
Avoidant coping will be assessed using the Mini-MAC Cognitive Avoidance subscale
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in avoidant coping
Délai: Baseline, 6 weeks, and 10 weeks
|
Avoidant coping will be assessed using the Brief COPE Self-Distraction, Denial, and Behavioral Disengagement subscales
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in depressive symptoms
Délai: Baseline, 6 weeks, and 10 weeks
|
Depressive symptoms will be assessed using the PHQ-8
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in anxiety
Délai: Baseline, 6 weeks, and 10 weeks
|
Anxiety will be assessed using the GAD-7
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in spiritual well-being
Délai: Baseline, 6 weeks, and 10 weeks
|
Spiritual well-being will be measured using the FACIT-SP.
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in sleep disturbance
Délai: Baseline, 6 weeks, and 10 weeks
|
Sleep disturbance will be assessed using the PROMIS Sleep Disturbance.
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in family communication
Délai: Baseline, 6 weeks, and 10 weeks
|
Family communication will be assessed using the Social Constraint Scale
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in interpersonal closeness
Délai: Baseline, 6 weeks, and 10 weeks
|
Interpersonal closeness will be assessed using the Perceived Interpersonal Closeness Scale.
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in acceptance of illness
Délai: Baseline, 6 weeks, and 10 weeks
|
Acceptance of illness will be assessed using the PEACE Scale.
|
Baseline, 6 weeks, and 10 weeks
|
Change from baseline in mindfulness
Délai: Baseline, 6 weeks, and 10 weeks
|
Mindfulness will be assessed using the FFMQ-SF Non-reactivity to Internal Experience and Acting with Awareness subscales.
|
Baseline, 6 weeks, and 10 weeks
|
Distress Thermometer
Délai: Baseline, 6 weeks, and 10 weeks
|
Distress will be assessed using the Distress Thermometer.
|
Baseline, 6 weeks, and 10 weeks
|
Intervention satisfaction and helpfulness
Délai: 6 weeks
|
Satisfaction and helpfulness with the Mindfulness intervention will be assessed using single-item investigator-created 7- and 10-point Likert scales, respectively (Mindfulness group only).
|
6 weeks
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Shelley A Johns, PsyD, Indiana University School of Medicine
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 1702223546
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Qualité de vie
-
Queens College, The City University of New YorkRecrutementPublication d'articles soumis à l'American Journal of Public HealthÉtats-Unis
-
Abramson Cancer Center of the University of PennsylvaniaRetiréPatients cancéreux subissant une greffe de cellules souches (RCT of ACP for Transplant)
-
Swansea UniversityComplétéA Bite of ACT '(BOA) Cours de psychoéducation en ligne sur la thérapie d'acceptation et d'engagement | Un contrôle de liste d'attenteRoyaume-Uni
-
Yale-NUS CollegeComplétéL'objectif de l'étude est les réponses des patients à un questionnaire de gestion de l'obésité administré par le SGH Life CenterSingapour
-
Central Hospital, Nancy, FranceInstitut National de la Santé Et de la Recherche Médicale, FranceComplétéInflammation | Maladies du système nerveux autonome | Choc, cardiogénique | Extra-Corporeal-Life-Support (ECLS)France
-
Yale-NUS CollegeComplétéL'objectif de l'étude est les réponses des patients à un questionnaire de gestion de l'obésité administré par le SGH Life CenterSingapour